GLP-1 Receptor Agonists and Breast Cancer Risk Reduction
An observational study links GLP-1 medications to lower breast cancer risk in overweight women, highlighting promising preventive potential while reinforcing continued screening and randomized research.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.